Elevai Labs signs international distribution agreement with ILIA International

ELEVAI LABS announces that it has signed an international distribution agreement with ILIA International covering the country of Taiwan. Chris Kraneiss, Chief Commercial Officer of Elevai Labs, Inc. commented: “It is with great pleasure that I announce the signing of ILIA International Ltd. as our exclusive distributor in Taiwan. From my past dealings in the region, I know that ILIA is very well respected in the Taiwanese market and is one of the leading aesthetic distributors in that territory. Exosome-based beauty has some of its earliest roots in the Asian region, and it is a testament to our quality, purity, proprietary technology, and advanced formulations that we have had such a rapid uptake on the continent. We believe that with this agreement ELEVAI will become one of the leading exosome providers in Taiwan, and that ILIA’s access to all leading aesthetic practices and clinics will set us on the proper course.”